Marketing-authorisation holder · United States
Xeris
6 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
6 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| DARANIDE50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · Tablet | Dichlorphenamide | United States | Not marketed | 1958 |
| GVOKE HYPOPEN0.5mg/0.1ml (0.5mg/0.1ml) | 1mg/0.2ml (1mg/0.2ml) · Solution | Glucagon | United States | Marketed | 2019 |
| GVOKE KIT1mg/0.2ml (1mg/0.2ml) · Solution | Glucagon | United States | Marketed | 2019 |
| GVOKE PFS0.5mg/0.1ml (0.5mg/0.1ml) | 1mg/0.2ml (1mg/0.2ml) · Solution | Glucagon | United States | Marketed | 2019 |
| GVOKE VIALDX1mg/0.2ml (1mg/0.2ml) · Solution | Glucagon | United States | Marketed | 2019 |
| KEVEYIS50mg · Tablet | Dichlorphenamide | United States | Marketed | 1958 |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 6 |